SHIGELLA TEST KIT MARKET ANALYSIS

Shigella Test Kit Market, By Test Type (Lateral flow assays, Enzyme-linked immunosorbent assay (ELISA), Polymerase chain reaction (PCR) assay, and Others), By Technology (Conventional diagnostic tests, Nucleic acid-based tests, and Others), By EndUsers (Hospitals, Diagnostic laboratories, Research institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Recent Developments

New product launches

In September 2020, Bio-Rad Laboratories, Inc., a life science research company, launched a new ELISA test for the detection of Shigella toxin in stool samples.
In October 2022, Thermo Fisher Scientific, a medical technology company, launched new test for common gastrointestinal bacteria such as Shigella spp

Acquisition and partnerships

In August 2020, Meridian Bioscience, Inc., manufactures, markets, and distributes diagnostic test kits, purified reagents, and related products acquired Exalenz Bioscience Ltd., a company that develops and markets diagnostic tests for gastrointestinal and liver diseases. The acquisition is expected to expand Meridian Bioscience, Inc.'s product portfolio in the gastrointestinal market.
In October 2019, QIAGEN N.V., a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research and McKesson Medical-Surgical Inc. announced a partnership to expand the distribution of QIAGEN's molecular diagnostic tests
In April 2019, Becton, Dickinson and Company (BD), a medical device company and Check-Points B.V. announced a partnership to develop and commercialize molecular diagnostic tests for the detection of antibiotic-resistant bacteria.